The current institutional shareholding score of Larimar Therapeutics Inc is 7.00, ranking 80 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 79.20%, representing a quarter-over-quarter decrease of 23.65%. The largest institutional shareholder is Steven Cohen, holding a total of 1.34M shares, representing 1.00% of shares outstanding, with 0.81% decrease in holdings.